Reports of TB medicine shortages misleading: Health Ministry
July 7, 2025
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • International
  • Opinion
  • Op Sindoor
  • More
    • Analysis
    • Sports
    • Defence
    • RSS in News
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
MAGAZINE
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • International
  • Opinion
  • Op Sindoor
  • More
    • Analysis
    • Sports
    • Defence
    • RSS in News
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS in News
  • Magazine
  • Read Ecopy
Home Bharat

Reports of TB medicine shortages misleading: Health Ministry

The Health Ministry has issued a statement refuting recent media reports that suggest a shortage of anti-Tuberculosis (TB) drugs in India

by WEB DESK
Sep 26, 2023, 11:00 pm IST
in Bharat, Health
FacebookTwitterWhatsAppTelegramEmail

Ministry of Health and Family Welfare has issued a statement refuting recent media reports that suggest a shortage of anti-Tuberculosis (TB) drugs in India and question the efficacy of these drugs under the National TB Elimination Programme (NTEP).

The Ministry has labelled these reports as vague and ill-informed, lacking specific information about the availability of anti-TB medicines in stock, read the Ministry of Health and Family Welfare press release.

Under the National TB Elimination Programme (NTEP), the treatment for drug-sensitive tuberculosis involves a regimen of four drugs available as 4 FDC (Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide) for two months, followed by three drugs available as 3 FDC (Isoniazid, Rifampicin, and Ethambutol) for an additional two months.

Importantly, there are sufficient stocks of all these drugs, with supplies lasting for six months or more.

For Multi-Drug Resistant TB, the treatment typically consists of four months of seven drugs, followed by five months of four drugs. In approximately 30 per cent of cases of drug-resistant TB, cycloserine and linezolid may be required, read the press release.

The procurement, storage, and distribution of anti-TB drugs and related materials are centrally managed under NTEP. In rare cases, states were requested to procure specific drugs locally for a limited period to ensure that individual patient care remains uninterrupted.

For instance, Maharashtra has procured Cycloserine Tablets centrally, and some states have delegated procurement to districts as needed.

The Ministry shared the current stock status of anti-TB drugs in Maharashtra and at the national level to dispel any doubts about shortages.

Stock Position at National Level (as of September 24, 2023)- Cycloserine – 250 mg: 14,79,857 units, Linezolid – 600 mg: 9,95,779 units, Delamanid – 50 mg: 11,37,802 units, Levofloxacin – 250 mg: 28,85,176 units, Levofloxacin – 500 mg: 33,27,130 units, Clofazimine – 100 mg: 12,86,360 units, Moxifloxacin – 400 mg: 2,72,49,866 units, Pyridoxine: 2,72,99,242 units, read the press release.

The Ministry emphasises that there is no shortage of essential anti-TB drugs, with over 15 months of stock available for Moxifloxacin 400 mg and Pyridoxine under NTEP.

Additionally, Delamanid 50 mg and Clofazimine 100 mg were procured in August 2023 and supplied to all states and Union Territories.

Purchase orders have been issued for the supply of Linezolid-600mg and Cap Cycloserine-250 mg in August 2023, with these drugs being dispatched to the States.

The Ministry of Health and Family Welfare assures that significant efforts are in place to ensure the availability of these crucial anti-TB drugs, with regular assessments conducted to evaluate stock positions at various levels, from central warehouses to peripheral health institutes.

Therefore, the media reports are deemed vague and ill-informed, not accurately reflecting the actual stock of anti-TB drugs in the country.

(with inputs from ANI)

Topics: Ministry of HealthTuberculosisTB medicineSocial Media Reports
ShareTweetSendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

Karnataka Shocker: Maulana who raped minor boy in West Bengal arrested from Karnataka

Next News

Pandit Deen Dayal Upadhyaya: A great visionary and a man who followed the philosophy of ‘integral humanism’

Related News

Union Health Minister J.P Nadda and others in the 9th National Summit on Good and Replicable Practices and Innovations in Public Healthcare in Puri

India set to eliminate TB by 2025: Union Health Minister JP Nadda

Representative image

Study finds designing self-destructing bacteria make effective tuberculosis vaccines

Representative image

New research on TB could change how we treat inflammatory disorders

Representative image

ICMR’s New TB Testing Technology: Affordable detection at just Rs 35

Representative image

Experts developing immune-enhancing therapies to treat TB: Study

Representative Image

Reports claiming significant rise in medicine prices are misleading: Ministry of Health

Load More

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Representative Image

China targets Rafale with fake propaganda after Ops Sindoor of India to hide own defence failures: French intelligence

RSS Akhil Bharatiya Prachar Pramukh, Sunil Ambekar and Delhi Prant Sanghchalak Dr Anil Aggarwal

RSS 100 Years | More than 1 Lakh Hindu Sammelans to take place across Bharat: Sunil Ambekar 

I was in Mumbai during 26/11, worked for Pakistani Army: Explosive confession of Tahawwur Rana to NIA

A Muslim woman named Tamanna embraced Sanatan Dharma and married her partner Chandan Maurya

Interfaith Marriage in UP: Tamanna leaves Islam, embraces Sanatan Dharma & marries Chandan Maurya in Shiva Mandir

1993 Mumbai Riots accused Arif Ali Hashmulla Khan arrested in Wadala

1993 Mumbai Riots: Wadala police arrest key accused Arif Ali Hashmulla Khan after 32 years

Tamil Nadu: Sea of Devotees throng Thiruchendur to witness Kumbabhishekam of Bhagwan Murugan

Representative Image

Bihar: Ajay Yadav lynched by Islamist mob on Muharram

Tripra Motha founder Pradyot Debbarma (Left) and Tripura Governor Indrasena Reddy (Right)

Tripra Motha founder Pradyot Debbarma calls for unity against infiltration; Party begins march from Agartala to Delhi

PM Narendra Modi

Five Nation Tour: Modi to visit Namibia, 1st by Indian PM trip in 30 years to secure minerals, energy ties, expand UPI

Kerala: Teachers’ Union accuses CPM govt of distorting Class 10 books to fuel hatred against political parties

Kerala: Teachers’ Union accuses CPM govt of distorting Class 10 books to fuel hatred against political parties

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
    • Global Commons
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
    • Podcast
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies